Skip to main content
Veterinary Medicines

P3-RHINOPLUS

Authorised
  • Turkey rhinotracheitis virus, strain VCO3, Inactivated
  • Newcastle disease virus, strain Ulster 2C, Inactivated
  • Avian paramyxovirus 3, strain PMV3, Inactivated

Product identification

Medicine name:
P3-RHINOPLUS
Active substance:
  • Turkey rhinotracheitis virus, strain VCO3, Inactivated
  • Newcastle disease virus, strain Ulster 2C, Inactivated
  • Avian paramyxovirus 3, strain PMV3, Inactivated
Target species:
  • Turkey
Route of administration:
  • Subcutaneous use

Product details

Active substance and strength:
  • Turkey rhinotracheitis virus, strain VCO3, Inactivated
    5.00
    log10 50% tissue culture infectious dose
    /
    0.50
    millilitre(s)
  • Newcastle disease virus, strain Ulster 2C, Inactivated
    8.00
    log 10 50% embryo infective dose
    /
    0.50
    millilitre(s)
  • Avian paramyxovirus 3, strain PMV3, Inactivated
    6.70
    log 10 50% embryo infective dose
    /
    0.50
    millilitre(s)
Pharmaceutical form:
  • Emulsion for injection
Withdrawal period by route of administration:
  • Subcutaneous use
    • Turkey
      • Meat and offal
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI01CA02
Authorisation status:
  • Valid
Authorised in:
  • Italy
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Boehringer Ingelheim Animal Health Italia S.p.A. In Breve Boehringer Ingelheim Ah It S.p.A.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Boehringer Ingelheim Animal Health Italia S.p.A. In Breve Boehringer Ingelheim Ah It S.p.A.
Responsible authority:
  • Ministry Of Health
Authorisation number:
This information is not available for this product.
Date of authorisation status change:

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Italian (PDF)
Published on: 6/03/2023